mastpharma® development & stability
Mast Group offers a range of services including mastpharma® development and stability for the evaluation of novel antimicrobial compounds for the pharmaceutical industry.
Utilising over 65 years of experience of development and manufacture of antimicrobial test products mastpharma® offers extra confidence in the success of the antimicrobial on final commercialisation.
We offer flexible and convenient services to provide pharmaceutical companies with confidence in quality and assist with easy distribution and integration for market evaluations.
mastpharma® development
In the disc development phase an antimicrobial susceptibility test (AST) disc containing a novel compound is formulated. Additionally, methods for the assay of its contents are verified. Initial stress studies identify the most suitable candidate formulation for the production of stable investigational use only (IUO) AST discs, preliminary QC criteria are generated during this process.
mastpharma® stability
For this service we offer a minimum of three replicate batches of product are manufactured and entered into real-time stability studies. Studies carried out over an 18 month period under both normal storage and additional stress conditions allow trending to be monitored and ensure final product retains effective performance for the duration of its allocated shelf life.
